Literature DB >> 19642931

Prion protein expression and release by mast cells after activation.

D James Haddon1, Michael R Hughes, Frann Antignano, David Westaway, Neil R Cashman, Kelly M McNagny.   

Abstract

In this study, we compared hematopoietic stem cells and mast cells, using microarray expression analysis, and identified the cellular prion protein (PrP(C)) as a potentially novel marker of mast cells. On further investigation, we found that PrP(C) is expressed on the surface of human and mouse mast cells, is rapidly released by mast cells upon activation, and is released in response to mast cell-dependent allergic inflammation in vivo. Because mast cells are long lived and traffic to the brain and central nervous system, our observations could have important implications for the transmission and pathology of prion diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19642931     DOI: 10.1086/605022

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

Review 1.  Anchorless risk or released benefit? An updated view on the ADAM10-mediated shedding of the prion protein.

Authors:  Behnam Mohammadi; Feizhi Song; Andreu Matamoros-Angles; Mohsin Shafiq; Markus Damme; Berta Puig; Markus Glatzel; Hermann Clemens Altmeppen
Journal:  Cell Tissue Res       Date:  2022-01-27       Impact factor: 5.249

2.  A Soluble PrPC Derivative and Membrane-Anchored PrPC in Extracellular Vesicles Attenuate Innate Immunity by Engaging the NMDA-R/LRP1 Receptor Complex.

Authors:  Elisabetta Mantuano; Pardis Azmoon; Michael A Banki; Christina J Sigurdson; Wendy M Campana; Steven L Gonias
Journal:  J Immunol       Date:  2021-11-22       Impact factor: 5.422

Review 3.  Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part I. a literature review.

Authors:  Emily Dexter; Qingzhong Kong
Journal:  Expert Rev Neurother       Date:  2021-09-02       Impact factor: 4.287

4.  Plasma soluble prion protein, a potential biomarker for sport-related concussions: a pilot study.

Authors:  Nam Pham; Hungbo Akonasu; Rhonda Shishkin; Changiz Taghibiglou
Journal:  PLoS One       Date:  2015-02-02       Impact factor: 3.240

Review 5.  Physiological Functions of the Cellular Prion Protein.

Authors:  Andrew R Castle; Andrew C Gill
Journal:  Front Mol Biosci       Date:  2017-04-06

6.  TUDCA-treated chronic kidney disease-derived hMSCs improve therapeutic efficacy in ischemic disease via PrPC.

Authors:  Yeo Min Yoon; SangMin Kim; Yong-Seok Han; Chul Won Yun; Jun Hee Lee; Hyunjin Noh; Sang Hun Lee
Journal:  Redox Biol       Date:  2019-02-16       Impact factor: 11.799

7.  Chronic Wasting Disease In Cervids: Prevalence, Impact And Management Strategies.

Authors:  Nelda A Rivera; Adam L Brandt; Jan E Novakofski; Nohra E Mateus-Pinilla
Journal:  Vet Med (Auckl)       Date:  2019-10-02

Review 8.  Prion disease and the innate immune system.

Authors:  Barry M Bradford; Neil A Mabbott
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

Review 9.  The Cellular Prion Protein: A Player in Immunological Quiescence.

Authors:  Maren K Bakkebø; Sophie Mouillet-Richard; Arild Espenes; Wilfred Goldmann; Jörg Tatzelt; Michael A Tranulis
Journal:  Front Immunol       Date:  2015-09-02       Impact factor: 7.561

10.  Prion protein is required for tumor necrosis factor α (TNFα)-triggered nuclear factor κB (NF-κB) signaling and cytokine production.

Authors:  Gui-Ru Wu; Tian-Chen Mu; Zhen-Xing Gao; Jun Wang; Man-Sun Sy; Chao-Yang Li
Journal:  J Biol Chem       Date:  2017-09-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.